APA (7th ed.) Citation

D, Z., W, H., M, B., MB, W., W, K., K, H., . . . AP, H. (2024). Cabergoline targets multiple pathways to inhibit PRL secretion and increases stromal fibrosis. European journal of endocrinology, 190(6), 467. https://doi.org/10.1093/ejendo/lvae055

Chicago Style (17th ed.) Citation

D, Zhang, Hugo W, Bergsneider M, Wang MB, Kim W, Han K, Vinters HV, and Heaney AP. "Cabergoline Targets Multiple Pathways to Inhibit PRL Secretion and Increases Stromal Fibrosis." European Journal of Endocrinology 190, no. 6 (2024): 467. https://doi.org/10.1093/ejendo/lvae055.

MLA (9th ed.) Citation

D, Zhang, et al. "Cabergoline Targets Multiple Pathways to Inhibit PRL Secretion and Increases Stromal Fibrosis." European Journal of Endocrinology, vol. 190, no. 6, 2024, p. 467, https://doi.org/10.1093/ejendo/lvae055.